CEVI — CellaVision AB Share Price
0.000.00%
Last trade - 00:00- SEK3.87bn
- SEK3.75bn
- SEK723.22m
- 93
- 13
- 11
- 29
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.21 | ||
| PEG Ratio (f) | 1.19 | ||
| EPS Growth (f) | 21.64% | ||
| Dividend Yield (f) | 1.78% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.75 | ||
| Price to Tang. Book | 11.81 | ||
| Price to Free Cashflow | 32.09 | ||
| Price to Sales | 5.36 | ||
| EV to EBITDA | 17.15 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 19.66% | ||
| Return on Equity | 18.37% | ||
| Operating Margin | 24.57% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 471.44 | 565.55 | 639.34 | 677.29 | 723.22 | 784.75 | 892.5 | 9.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -6.88 | +35.72 | -3.45 | +7.68 | +7.99 | +21.07 | +22.64 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Directors
- Soren Mellstig NEC (70)
- Simon Ostergaard PRE (50)
- Magnus Blixt CFO (56)
- Yve Van Thorenburg VPR
- Peter Wilson VPR (54)
- Maria Morin VPR (47)
- Adam Morell VPR (45)
- Jeppe Brandstrup VBD (37)
- Julien Veyssy OTH (38)
- Christer Fahraeus DRC (56)
- Gunnar Hansen DRC (42)
- Markus Kristoffersson DRC (41)
- Asa Hedin IND (59)
- Anna Malm Bernsten IND (60)
- Niklas Prager IND (51)
- Juergen Riedl IND (44)
- Stefan Wolf IND (57)
- Mikael Worning IND (59)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 14th, 1994
- Public Since
- May 28th, 2007
- No. of Shareholders
- 6,862
- No. of Employees
- 236
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 23,851,547
- Address
- Mobilvagen 12, LUND, 223 62
- Web
- https://www.cellavision.com/
- Phone
- +46 464601600
- Contact
- Adele Horn
- Auditors
- KPMG AB
Upcoming Events for CEVI
CellaVision AB Annual Shareholders Meeting
Dividend For CEVI.ST - 2.5000 SEK
Q2 2025 CellaVision AB Earnings Release
Similar to CEVI
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the CellaVision AB share price?
As of Today at 19:50 UTC, shares in CellaVision AB are trading at SEK162.40. This share price information is delayed by 15 minutes.
How has the CellaVision AB share price performed this year?
Shares in CellaVision AB last closed at SEK162.40 and the price had moved by -29.24% over the past 365 days. In terms of relative price strength the CellaVision AB share price has underperformed the FTSE Global All Cap Index by -31.01% over the past year.
What are the analyst and broker recommendations for CellaVision AB?
The overall consensus recommendation for CellaVision AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the CellaVision AB dividend yield?
The CellaVision AB dividend yield is 1.54% based on the trailing twelve month period.
Does CellaVision AB pay a dividend?
Last year, CellaVision AB paid a total dividend of SEK2.50, and it currently has a trailing dividend yield of 1.54%.Looking ahead, shares in CellaVision AB are due to go ex-dividend on 2025-05-07 and the next dividend pay date is 2025-05-13.
When does CellaVision AB next pay dividends?
CellaVision AB are due to go ex-dividend on 2025-05-07 and the next dividend pay date is 2025-05-13. The historic dividend yield on CellaVision AB shares is currently 1.54%.
How do I buy CellaVision AB shares?
To buy shares in CellaVision AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CellaVision AB?
As of the previous close price of SEK162.40, shares in CellaVision AB had a market capitalisation of SEK3.87bn.
Where are CellaVision AB shares listed?
Here are the trading details for CellaVision AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: CEVI
What kind of share is CellaVision AB?
Based on an overall assessment of its quality, value and momentum CellaVision AB is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CellaVision AB share price forecast for 2025?
The analyst consensus target price for shares in CellaVision AB is SEK229.33. That is 41.21% above the last closing price of SEK162.40.
Analysts covering CellaVision AB currently have a consensus Earnings Per Share (EPS) forecast of SEK7.14 for the next financial year.
Find out moreWhat is the trend in the CellaVision AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CellaVision AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -37.74%.
As of the last closing price of SEK162.40, shares in CellaVision AB were trading -28.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CellaVision AB PE Ratio?
The CellaVision AB PE ratio based on its reported earnings over the past 12 months is 21.21. The shares last closed at SEK162.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CellaVision AB?
CellaVision AB's management team is headed by:
- Soren Mellstig - NEC
- Simon Ostergaard - PRE
- Magnus Blixt - CFO
- Yve Van Thorenburg - VPR
- Peter Wilson - VPR
- Maria Morin - VPR
- Adam Morell - VPR
- Jeppe Brandstrup - VBD
- Julien Veyssy - OTH
- Christer Fahraeus - DRC
- Gunnar Hansen - DRC
- Markus Kristoffersson - DRC
- Asa Hedin - IND
- Anna Malm Bernsten - IND
- Niklas Prager - IND
- Juergen Riedl - IND
- Stefan Wolf - IND
- Mikael Worning - IND